Skip to content

Doximity DOCS Financing Cash Flow

Financing Cash Flow at other companies

Microsoft logo
MicrosoftMSFT
-$11.35B+12.9%
Veeva Systems logo
Veeva SystemsVEEV
-$262.53M-1,388%
Solventum logo
SolventumSOLV
-$50M+64.0%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
-$70.02M+18.6%
Cardinal Health logo
Cardinal HealthCAH
-$483M
Cencora logo
CencoraCOR
$3.98B

Other financials

Income statement

See full
Revenue$145.4M+5.1%
Gross profit$126.0M+1.7%
Operating income$24.8M-49.0%
Net income$19.1M-69.4%
EPS (diluted)$0.10-67.7%

Balance sheet

See full
Cash & equivalents$219.2M+4.6%
Total debt$10.2M-17.8%
Total equity$950.8M-12.2%
Total assets$1.1B-11.1%

Cash flow

See full
Operating cash flow$109.5M+11.2%
CapEx-
Free cash flow$81.6M-17.1%

Valuation

See full
Market cap$3.74B-60.5%
Enterprise value$3.53B-61.7%
P/E19.1×-23.3×
P/S5.8×-10.8×

Profitability

See full
Gross margin89.1%-1.1pp
Operating margin33.3%-6.6pp
Net margin30.4%-8.7pp
FCF margin50.6%+2.7pp

Returns & leverage

See full
Return on equity19.3%-3.2pp
Debt / equity0.0×
Current ratio6.1×-0.9×

Where this comes from

Reported directly by Doximity in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Doximity’s 10-K, filed May 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about Doximity's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Doximity's financing cash flow?
Doximity (DOCS) reported financing cash flow of -$93.16M in Q1 2026.
How has Doximity's financing cash flow changed year-over-year?
Doximity's financing cash flow decreased by 214.0% year-over-year, from -$29.67M to -$93.16M.
What is the long-term trend for Doximity's financing cash flow?
Over 4 years (2022 to 2026), Doximity's financing cash flow has grown at a -4.6% compound annual growth rate (CAGR), from $560.42M to -$464.06M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.